| Literature DB >> 23957001 |
Arshya Hashim1, M Salman Khan, Mohd Sajid Khan, Mohd Hassan Baig, Saheem Ahmad.
Abstract
The present study on Phyllanthus virgatus, known traditionally for its remedial potential, for the first time provides descriptions of the antioxidant and inhibition of α -amylase enzyme activity first by in vitro analyses, followed by a confirmatory in silico study to create a stronger biochemical rationale. Our results illustrated that P. virgatus methanol extract exhibited strong antioxidant and oxidative DNA damage protective activity than other extracts, which was well correlated with its total phenolic content. In addition, P. virgatus methanol extract strongly inhibited the α -amylase activity (IC50 33.20 ± 0.556 μ g/mL), in a noncompetitive manner, than acarbose (IC50 76.88 ± 0.277 μ g/mL), which showed competitive inhibition. Moreover, this extract stimulated the glucose uptake activity in 3T3-L1 cells and also showed a good correlation between antioxidant and α -amylase activities. The molecular docking studies of the major bioactive compounds (9,12-octadecadienoic acid, asarone, 11-octadecenoic acid, and acrylic acid) revealed via GC-MS analysis from this extract mechanistically suggested that the inhibitory property may be due to the synergistic effect of these bioactive compounds. These results provide substantial basis for the future use of P. virgatus methanol extract and its bioactive compound in in vivo system for the treatment and management of diabetes as well as in the related condition of oxidative stress.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23957001 PMCID: PMC3703720 DOI: 10.1155/2013/729393
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Treatment protocol for glucose uptake assay.
| S. no. | Incubation medium |
|---|---|
| Group 1 | 1000 |
| Group 2 | 900 |
| Group 3 | 900 |
| Group 4 | 900 |
| Group 5 | 800 |
| Group 6 | 800 |
| Group 7 | 700 |
Phytochemical constituents of sequentially extracted P. virgatus fractions.
|
| Tannins | Terpenoids | Phenols | Flavanoids | Protein | Glucose | Reducing sugar |
|---|---|---|---|---|---|---|---|
|
| − − | − − | − − | − − | ++ | − − | − − |
| DCM | ++ | + | − − | − − | ++ | − − | − − |
| EtOAc | − − | ++ | − − | +++ | ++ | + | + |
| Water | +++ | + | ++ | +++ | +++ | − − | − |
| MeOH | ++ | ++ | ++ | +++ | + | ++ | + |
Ferric reducing antioxidant potential and total phenol content of P. virgatus extracts. The data represents mean ± S.D. of six FRAP and three TPC experiments.
| Extracts/reference | FRAP value ( | TPC |
|---|---|---|
|
| 0.442 ± 0.126 | 2.61 ± 0.017 |
| DCM | 0.924 ± 0.419 | 1.92 ± 0.001 |
| EtOAc | 1.255 ± 0.53 | 37.42 ± 0.010 |
| MeOH | 28.61 ± 0.2.184 | 176.68 ± 0.032 |
| Water | 5.69 ± 9.7 | 67.766 ± 0.029 |
| Ascorbic acid | 13.05 ± 3.131 |
Figure 1Linear correlation between the amount of TPC and antioxidant capacity (FRAP) of P. virgatus in various solvent systems.
Figure 2DPPH radical scavenging activity of different extracts of P. virgatus and standard ascorbic acid. The data represent percent scavenging of DPPH radicals. The results are mean ± S.D. of three parallel measurements. Nonsignificant (ns), *P < 0.05, ∗∗ P < 0.01, ***P < 0.001 versus 0 μg/mL.
IC50 values of P. virgatus against DPPH radicals, hydroxyl radicals, and α-amylase activity.
| Activity | Plant extract/standard | IC50 ( |
|---|---|---|
| DPPH radical scavenging |
| 18.59 ± 0.515 |
|
| 40.36 ± 2.35 | |
|
| NS | |
|
| NS | |
|
| NS | |
| Ascorbic acid | 10.72 ± 0.33 | |
|
| ||
| Hydroxyl radical scavenging |
| 12.53 ± 2.38 |
|
| 14.56 ± 0.389 | |
| Mannitol | NS | |
|
| ||
|
|
| 33.20 ± 0.556 |
| Acarbose | 76.88 ± 0.277 | |
Figure 3Hydroxyl radical scavenging activity of the P. virgatus MeOH, water extract, and reference compound mannitol. The data represents the percentage of inhibition of deoxyribose degradation. The results are expressed as mean ± S.D. (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 versus 0 μg/mL.
Figure 4Effect of P. virgatus water and MeOH extracts on damaged supercoiled pUC18 plasmid DNA. Lane 1: pUC18 DNA + PBS; lane 2: pUC18 DNA + Fenton's reagent; lane 3: DNA + Fenton's reagent + water extract (50 μg/mL); lane 4: DNA + Fenton's reagent + water extract (100 μg/mL); lane 5: DNA + Fenton's reagent + water extract (200 μg/mL); lane 6: DNA + Fenton's reagent + MeOH extract (50 μg/mL); lane 7: DNA + Fenton's reagent + MeOH extract (100 μg/mL); lane 8: DNA + Fenton's reagent + MeOH extract (200 μg/mL); lane 9: Mannitol (200 μg/mL).
Figure 5Screening of α-amylase inhibitory property of various extracts of P. virgatus. Results are mean ± S.D. of three parallel measurements. Nonsignificant (ns), **P < 0.01, ***P < 0.001 versus 0 μg/mL.
Figure 6Concentration-dependent inhibition of P. virgatus methanol extract and reference compound acarbose. The results are expressed as mean ± S.D. of three parallel experiments. Nonsignificant (ns), ***P < 0.001 versus 0 μg/mL.
Figure 7Lineweaver-Burk double reciprocal plot of 1/v versus 1/[S] of acarbose (a) and P. virgatus methanol extract (b) against α-amylase.
Figure 8Linear correlation between the DPPH radical scavenging activity and α-amylase inhibition of P. virgatus methanol extract.
Figure 9Effect of P. virgatus methanol extract on glucose utilization in differentiated 3T3-L1 cell line. Results are mean ± S.D. of three parallel measurements. **P < 0.01 and ***P < 0.001 indicate significance compared to unstimulated cells.
Figure 10Percent of cell viability of 3T3-L1 adipocytes treated with methanol extract of P. virgatus at various concentrations.
Major constituents of P. virgatus methanol extract revealed via GC-MS analysis.
| Peak | R.T | Compound | Molecular | Molecular weight | Area% |
|---|---|---|---|---|---|
| 1 | 16.508 | Benzenedicarboxylic acid | C12H14O4 | 222 | 7.1 |
| 2 | 17.005 | 2,4,5-Trimethoxy propenyl benzene | C12H16O3 | 208 | 27 |
| 3 | 18.508 | Tridecyl ester | C16H30O2 | 254 | 8.77 |
| 4 | 22.643 | Hexadecanoic acid | C17H34O2 | 270 | 13.36 |
| 5 | 26.557 | 9,12-Octadecadienoic acid | C19H34O2 | 294 | 16.91 |
| 6 | 26.798 | 11-Octadecenoic acid | C19H34O3 | 294 | 22.29 |
| 7 | 27.517 | 6-Octadecynoic acid | C19H34O4 | 294 | 4.56 |
Figure 11Binding orientation of the crystallized (red) and redocked (blue) acarbose.
Molecular docking results of pancreatic α-amylase with different compounds of P. virgatus methanol extract.
| Compounds | Binding energy (kcal/mol) | Residues involved |
|---|---|---|
| Hexadecanoic acid | −4.58 | TRP-59, TYR-62, GLN-63, LEU-162, LEU-165, ADP-197, ALA-198, LYS-200, HIS-201, ILE-235, ASP-300 |
| Asarone | −5.21 | LEU-162, ASP-197, ALA-198, LYS-200, HIS-201, GLU-233, VAL-234, ILE-235 |
| Phthalic acid | −4.00 | TYR-151, ALA-198, LYS-200, HIS-201, GLU-233, ILE-235 |
| Acrylic acid | −5.19 | TRP-59, TYR-62, GLN-63, LEU-162, LEU-165, LYS-200, HIA-201, GLU-233, VL-234, ILE-235 |
| 11-Octadecenoic acid | −5.55 | TRP-59, TYR-62, LEU-162, LEU-165, LYS-200, HIS-201, GLU-233, VAL-234, ILE-235 |
| 9,12-Octadecadienoic acid | −6.11 | TRP-59, TYR-62, GLN-63, LEU-162, LEU-165, ALA-198, LYS-200, HIS-201, GLU-233, ILE-235 |
| 6-Octadecynoic acid | −4.92 | TRP-58, TRP-59, TYR-62, HIS-101, LEU-162, VAL-163, LEU-165, ASP-197, ALA-198, LYS-200, HIS-201, GLU-233, ILE-235, HIS-305 |
Figure 12Binding pattern of the compounds depicted via GC-MS analyses within the active site of pancreatic α-amylase.